NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
DSS, Inc. operates in product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions. Also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focus on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.1M | $20.3M | $28.4M | $25.9M | $19.1M | $20.8M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$11.4M | -$23.5M | -$30.0M | -$50.8M | -$42.6M | -$14.4M |
| Net income | $1.9M | -$33.1M | -$59.8M | -$60.6M | -$46.9M | -$23.9M |
| Diluted EPS | $0.03 | -$0.68 | -$6.84 | -$8.20 | -$6.63 | — |
| Operating cash flow | — | -$9.0M | -$27.0M | -$19.2M | -$8.8M | -$9.1M |
| Free cash flow | — | -$23.3M | -$28.8M | -$20.0M | -$8.9M | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -548.1% | -116.0% | -105.6% | -195.8% | -223.1% | -69.5% |
| Net margin | 91.1% | -163.3% | -210.8% | -233.8% | -245.6% | -115.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2M | $5.6M | $5.4M | $5.0M | $5.3M | $6.4M | $4.1M | $4.3M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$4.9M | -$4.7M | -$28.3M | -$3.7M | -$3.4M | -$3.2M | -$4.0M | -$5.5M |
| Net income | -$4.7M | -$5.3M | -$32.9M | -$4.8M | — | — | — | -$5.8M |
| Diluted EPS | -$0.66 | -$0.75 | -$4.64 | — | — | — | — | — |
| Operating cash flow | -$3.4M | -$315,000.00 | -$2.9M | $168,000.00 | $262,000.00 | -$8.0M | -$1.6M | -$133,000.00 |
| Free cash flow | -$3.5M | -$315,000.00 | -$3.0M | $116,000.00 | $170,000.00 | -$8.1M | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -117.2% | -83.4% | -522.7% | -75.2% | -64.8% | -50.6% | -98.1% | -126.7% |
| Net margin | -111.2% | -94.4% | -606.7% | -96.4% | — | — | — | -134.4% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Latest 1 transaction.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.